{"id":75352,"date":"2025-12-31T06:28:29","date_gmt":"2025-12-30T21:28:29","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/complex-injectables-market-mordor\/"},"modified":"2026-10-02T19:44:18","modified_gmt":"2026-10-02T10:44:18","slug":"complex-injectables-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/complex-injectables-market-mordor\/","title":{"rendered":"\u8907\u96d1\u6ce8\u5c04\u5264\u5e02\u5834 \u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/complex-injectables-market-1728471042332-Competitive-Landscape-and-Logo-Format-Copy-Complex-Injectable.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/complex-injectables-market-size-image-1735475352578.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u52d5\u5411<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u6162\u6027\u75be\u60a3\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u898f\u5236\u652f\u63f4\u3068\u627f\u8a8d<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u85ac\u5264\u9001\u9054\u306b\u304a\u3051\u308b\u6280\u8853\u9769\u65b0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u9ad8\u3044\u958b\u767a\u30b3\u30b9\u30c8<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u88fd\u9020\u306e\u8907\u96d1\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 (\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 &#8211; \u7c73\u30c9\u30eb)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u6295\u4e0e\u7d4c\u8def\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u7b4b\u8089\u5185 (IM)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u9759\u8108\u5185 (IV)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u76ae\u4e0b<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u88fd\u5264\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u30ea\u30dd\u30bd\u30fc\u30e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u30de\u30a4\u30af\u30ed\u30b9\u30d5\u30a3\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u305d\u306e\u4ed6\u306e\u88fd\u5264<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u85ac\u5264\u5206\u5b50\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u30ea\u30e5\u30fc\u30d7\u30ed\u30ea\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u30aa\u30af\u30c8\u30ec\u30aa\u30c1\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 \u30da\u30ac\u30b9\u30d1\u30eb\u30ac\u30fc\u30bc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.5 \u30ea\u30b9\u30da\u30ea\u30c9\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.6 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u7528\u9014\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5fc3\u8840\u7ba1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u304c\u3093<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u4e2d\u67a2\u795e\u7d4c\u7cfb\u75be\u60a3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u7cd6\u5c3f\u75c5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u5185\u5206\u6ccc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.6 \u305d\u306e\u4ed6\u306e\u75be\u60a3<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 AbbVie, Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 Accord BioPharma, Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 Bristol-Myers Squibb Company<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 Ferring Pharmaceuticals<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 Fresenius Kabi<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 Indivior PLC<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 Pfizer Inc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 Takeda Pharmaceutical Company Limited<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 Tolmar Pharmaceuticals, Inc<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u300c\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u306e\u898f\u6a21\u3068\u30b7\u30a7\u30a2\u5206\u6790\uff1a\u6210\u9577\u3001\u30c8\u30ec\u30f3\u30c9\u3001\u4e88\u6e2c\uff082025\u5e74\uff5e2030\u5e74\uff09\u300d\u3068\u984c\u3055\u308c\u305f\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f1,112\u51045,000\u4e07\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u307e\u3067\u306b1,674\u51044,000\u4e07\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3051\u308b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f8.52%\u3067\u3059\u3002\u3053\u306e\u5e02\u5834\u306b\u304a\u3044\u3066\u3001\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u3067\u3042\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u3067\u3042\u308b\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5e02\u5834\u306e\u6210\u9577\u306f\u3001\u4e3b\u306b\u304c\u3093\u3084\u5fc3\u8840\u7ba1\u75be\u60a3\u306a\u3069\u306e\u6162\u6027\u75be\u60a3\u306e\u5897\u52a0\u3001\u85ac\u5264\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u306b\u304a\u3051\u308b\u6280\u8853\u7684\u9032\u6b69\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u3078\u306e\u9700\u8981\u306e\u9ad8\u307e\u308a\u3001\u305d\u3057\u3066\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u627f\u8a8d\u306e\u5897\u52a0\u3092\u4f34\u3046\u652f\u63f4\u7684\u306a\u898f\u5236\u67a0\u7d44\u307f\u3068\u3044\u3063\u305f\u8981\u56e0\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6162\u6027\u75be\u60a3\u306e\u7f79\u60a3\u7387\u306e\u4e0a\u6607\u306f\u3001\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u9700\u8981\u3092\u5927\u304d\u304f\u62bc\u3057\u4e0a\u3052\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u7c73\u56fd\u304c\u3093\u5354\u4f1a\u306f\u3001\u65b0\u898f\u304c\u3093\u60a3\u8005\u6570\u304c2023\u5e74\u306e190\u4e07\u4eba\u304b\u30892024\u5e74\u306b\u306f200\u4e07\u4eba\u306b\u5897\u52a0\u3059\u308b\u3068\u63a8\u5b9a\u3057\u3066\u304a\u308a\u3001\u4e73\u304c\u3093\u3001\u80ba\u304c\u3093\u3001\u8840\u6db2\u304c\u3093\u304c\u4e3b\u306a\u8a3a\u65ad\u5bfe\u8c61\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u540c\u69d8\u306b\u3001\u30d6\u30e9\u30b8\u30eb\u306e\u56fd\u7acb\u304c\u3093\u7814\u7a76\u6240\u306e\u63a8\u5b9a\u3067\u306f\u3001\u975e\u9ed2\u8272\u816b\u76ae\u819a\u304c\u3093\u3092\u9664\u304d\u30012023\u5e74\u304b\u30892025\u5e74\u306e\u9593\u306b\u7d0470\u4e074,000\u4ef6\u306e\u65b0\u898f\u304c\u3093\u75c7\u4f8b\u304c\u8a3a\u65ad\u3055\u308c\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u304c\u3093\u306e\u9a5a\u304f\u3079\u304d\u8ca0\u62c5\u306f\u3001\u9ad8\u5ea6\u306a\u85ac\u5264\u9001\u9054\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u3001\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u306e\u9700\u8981\u3092\u4fc3\u9032\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u307e\u305f\u3001\u69d8\u3005\u306a\u6162\u6027\u75be\u60a3\u306e\u7ba1\u7406\u306b\u304a\u3051\u308b\u8907\u5408\u6ce8\u5c04\u5264\u306e\u9700\u8981\u5897\u52a0\u3068\u3001\u305d\u306e\u4f7f\u7528\u306b\u4f34\u3046\u9ad8\u3044\u5b89\u5168\u6027\u3082\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u9700\u8981\u3092\u652f\u3048\u3001\u5e02\u5834\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u30022023\u5e748\u6708\u306bDrug Delivery and Translational Research\u8a8c\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u306b\u3088\u308b\u3068\u3001\u6162\u6027\u75be\u60a3\u306e\u9032\u884c\u671f\u306b\u304a\u3051\u308b\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u7ba1\u7406\u306b\u304a\u3051\u308b\u6709\u52b9\u6027\u304b\u3089\u3001\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u9700\u8981\u304c\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u8a18\u4e8b\u306f\u3001\u30de\u30a4\u30af\u30ed\u30b9\u30d5\u30a3\u30a2\u3001\u30ca\u30ce\u7c92\u5b50\u3001\u61f8\u6fc1\u6db2\u3001\u30ea\u30dd\u30bd\u30fc\u30e0\u306a\u3069\u306e\u65b0\u898f\u975e\u7d4c\u53e3\u88fd\u54c1\u304c\u3001\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u5b89\u5168\u6027\u3068\u9001\u9054\u3092\u6539\u5584\u3057\u305f\u3068\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u85ac\u5264\u88fd\u54c1\u306e\u6cbb\u7642\u6fc3\u5ea6\u3092\u5411\u4e0a\u3055\u305b\u308b\u8907\u5408\u6ce8\u5c04\u5264\u306e\u91cd\u8981\u306a\u5f79\u5272\u306f\u3001\u30ea\u30dd\u30bd\u30fc\u30e0\u3084\u5fae\u7c92\u5b50\u3092\u542b\u3080\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u5264\u306b\u6210\u9577\u306e\u52e2\u3044\u3092\u3082\u305f\u3089\u3057\u3001\u696d\u754c\u3067\u306e\u63a1\u7528\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e745\u6708\u306bCancer Nanotechnology\u8a8c\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u3067\u306f\u3001\u30ea\u30dd\u30bd\u30fc\u30e0\u30d9\u30fc\u30b9\u306e\u85ac\u5264\u9001\u9054\u304c\u6297\u304c\u3093\u5264\u306e\u816b\u760d\u6a19\u7684\u5316\u80fd\u529b\u3092\u5411\u4e0a\u3055\u305b\u3001\u816b\u760d\u90e8\u4f4d\u3067\u306e\u85ac\u5264\u84c4\u7a4d\u3092\u5897\u52a0\u3055\u305b\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u53c2\u52a0\u8005\u306b\u3088\u308b\u9ad8\u5ea6\u306a\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u958b\u767a\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u3082\u3001\u696d\u754c\u306e\u6210\u9577\u3092\u3055\u3089\u306b\u4fc3\u9032\u3059\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3067\u3059\u3002\u4f8b\u3048\u3070\u30012023\u5e7412\u6708\u306b\u306f\u3001Zydus Worldwide DMCC\u304cDaewoong Pharmaceutical Co Ltd\u3068\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3092\u7de0\u7d50\u3057\u3001\u7c73\u56fd\u5e02\u5834\u5411\u3051\u306b6\u3064\u306e\u7528\u91cf\u5f37\u5ea6\u306e\u30ea\u30e5\u30fc\u30d7\u30ed\u30ec\u30ea\u30f3\u9162\u9178\u30c7\u30dd\u61f8\u6fc1\u6db2\u3092\u5171\u540c\u958b\u767a\u30fb\u5546\u696d\u5316\u3059\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u8907\u5408\u6ce8\u5c04\u5264\u306e\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306e\u8907\u96d1\u3055\u3084\u88fd\u54c1\u306e\u9ad8\u30b3\u30b9\u30c8\u306f\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u306e\u5e02\u5834\u6210\u9577\u3092\u963b\u5bb3\u3059\u308b\u8981\u56e0\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>\u304c\u3093\u5206\u91ce\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u8457\u3057\u3044\u6210\u9577\u7387\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u304c\u3093\u306e\u7f79\u60a3\u7387\u306e\u6025\u5897\u3001\u304c\u3093\u3092\u7ba1\u7406\u3059\u308b\u305f\u3081\u306e\u9ad8\u5ea6\u306a\u6cbb\u7642\u6cd5\u3078\u306e\u9700\u8981\u306e\u5897\u52a0\u3001\u304c\u3093\u5411\u3051\u8907\u5408\u6ce8\u5c04\u5264\u304a\u3088\u3073\u9ad8\u5ea6\u306a\u85ac\u5264\u9001\u9054\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u958b\u767a\u3059\u308b\u305f\u3081\u306e\u5e02\u5834\u53c2\u52a0\u8005\u306e\u53d6\u308a\u7d44\u307f\u306e\u5f37\u5316\u3001\u305d\u3057\u3066\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u627f\u8a8d\u306e\u5897\u52a0\u3068\u3044\u3063\u305f\u8981\u56e0\u306b\u3088\u308a\u3001\u304c\u3093\u306e\u5fdc\u7528\u5206\u91ce\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6709\u5229\u306a\u6210\u9577\u6a5f\u4f1a\u3092\u76ee\u306e\u5f53\u305f\u308a\u306b\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u304c\u3093\u306e\u8ca0\u62c5\u306e\u5897\u52a0\u306f\u3001\u304c\u3093\u5411\u3051\u8907\u5408\u6ce8\u5c04\u5264\u306e\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u63a1\u7528\u3092\u652f\u63f4\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u30ab\u30ca\u30c0\u304c\u3093\u5354\u4f1a\u306e2024\u5e74\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u3001\u30ab\u30ca\u30c0\u306e\u304c\u3093\u60a3\u8005\u6570\u306f2023\u5e74\u306e23\u4e079,100\u4eba\u304b\u30892024\u5e74\u306b\u306f24\u4e077,100\u4eba\u306b\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u30ab\u30ca\u30c0\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u304c\u3093\u306e\u7a2e\u985e\u306b\u306f\u3001\u4e73\u304c\u3093\u3001\u524d\u7acb\u817a\u304c\u3093\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002\u540c\u69d8\u306b\u3001\u7c73\u56fd\u304c\u3093\u5354\u4f1a\u306b\u3088\u308b\u3068\u3001\u7c73\u56fd\u306e\u4e73\u304c\u3093\u306e\u8ca0\u62c5\u306f\u8457\u3057\u304f\u5897\u52a0\u3057\u3001\u7dcf\u75c7\u4f8b\u6570\u306f2023\u5e74\u306e30\u4e07590\u4eba\u304b\u30892024\u5e74\u306b\u306f31\u4e073,510\u4eba\u306b\u5897\u52a0\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u304c\u3093\u5411\u3051\u8907\u5408\u6ce8\u5c04\u5264\u3092\u958b\u767a\u3059\u308b\u305f\u3081\u306e\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u306e\u5897\u52a0\u306f\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u3067\u305d\u306e\u5546\u696d\u5316\u3092\u62e1\u5927\u3059\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3067\u3059\u30022024\u5e749\u6708\u306eClinical Trial.Gov\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u3001\u73fe\u5728\u3001\u69d8\u3005\u306a\u304c\u3093\u306b\u5bfe\u3059\u308b\u8907\u5408\u6ce8\u5c04\u5264\u306e\u6709\u52b9\u6027\u3092\u8a55\u4fa1\u3059\u308b32\u306e\u6d3b\u52d5\u4e2d\u306e\u7814\u7a76\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u53c2\u52a0\u8005\u306b\u3088\u308b\u304c\u3093\u5411\u3051\u65b0\u898f\u6ce8\u5c04\u5264\u306e\u958b\u767a\u3068\u767a\u58f2\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u306e\u5f37\u5316\u3082\u3001\u3053\u306e\u5206\u91ce\u306b\u6210\u9577\u6a5f\u4f1a\u3092\u3082\u305f\u3089\u3059\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012023\u5e7410\u6708\u306b\u306f\u3001Panacea Biotec\u304c\u3001\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u3001\u8ee2\u79fb\u6027\u4e73\u304c\u3093\u3001\u81b5\u81d3\u817a\u304c\u3093\u306e\u7ba1\u7406\u306b\u9069\u5fdc\u3055\u308c\u308b\u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb\u30bf\u30f3\u30d1\u30af\u8cea\u7d50\u5408\u7c92\u5b50\u6ce8\u5c04\u7528\u61f8\u6fc1\u6db2\uff08\u30a2\u30eb\u30d6\u30df\u30f3\u7d50\u5408\uff09\u3092\u30ab\u30ca\u30c0\u5e02\u5834\u3067\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u540c\u69d8\u306b\u3001Cipla Limited\u3068\u305d\u306e\u5b8c\u5168\u5b50\u4f1a\u793e\u3067\u3042\u308bCipla USA Inc\u306f\u3001\u30ea\u30e5\u30fc\u30d7\u30ed\u30ec\u30ea\u30f3\u9162\u9178\u6ce8\u5c04\u7528\u30c7\u30dd22.5mg\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u88fd\u54c1\u306f\u3001505(b)(2)\u898f\u5236\u7d4c\u8def\u306b\u57fa\u3065\u3044\u3066\u63d0\u51fa\u3055\u308c\u305f\u65b0\u85ac\u627f\u8a8d\u7533\u8acb\uff08NDA\uff09\u306e\u5f8c\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08US FDA\uff09\u304b\u3089\u627f\u8a8d\u3092\u53d7\u3051\u307e\u3057\u305f\u3002<\/p>\n<p>\u5317\u7c73\u304c\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u3067\u91cd\u8981\u306a\u5e02\u5834\u5730\u4f4d\u3092\u5360\u3081\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u9ad8\u3044\u6210\u9577\u7387\u3092\u793a\u3059\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u5317\u7c73\u306f\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u3067\u91cd\u8981\u306a\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u304a\u308a\u3001\u9ad8\u3044\u6210\u9577\u7387\u3092\u793a\u3059\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u65b0\u898f\u6ce8\u5c04\u5264\u3078\u306e\u9700\u8981\u306e\u5897\u52a0\u3068\u3001\u8907\u5408\u6ce8\u5c04\u5264\u306e\u898f\u5236\u627f\u8a8d\u306e\u6025\u5897\u3068\u3044\u3063\u305f\u8981\u56e0\u304c\u3001\u5730\u57df\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u4e3b\u8981\u306a\u5e02\u5834\u53c2\u52a0\u8005\u306e\u5b58\u5728\u3068\u3001\u5f7c\u3089\u304c\u5b9f\u65bd\u3059\u308b\u69d8\u3005\u306a\u6709\u6a5f\u7684\u304a\u3088\u3073\u7121\u6a5f\u7684\u958b\u767a\u304c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u696d\u754c\u62e1\u5927\u3092\u3055\u3089\u306b\u52a0\u901f\u3055\u305b\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5730\u57df\u306b\u304a\u3051\u308b\u6162\u6027\u75be\u60a3\u306e\u8ca0\u62c5\u306e\u5897\u52a0\u306f\u3001\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u9700\u8981\u3092\u5897\u5927\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3067\u3059\u3002\u4f8b\u3048\u3070\u3001\u30ab\u30ca\u30c0\u5fc3\u81d3\u8840\u7ba1\u5b66\u4f1a\u306e2023\u5e744\u6708\u306e\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u3001\u5fc3\u623f\u7d30\u52d5\uff08AFib\uff09\u306f\u30ab\u30ca\u30c0\u3067\u518d\u767a\u6027\u306e\u4e0d\u6574\u8108\u306e\u4e00\u7a2e\u3067\u3042\u308a\u3001\u4e00\u822c\u4eba\u53e3\u306e\u7d041%\u304b\u30892%\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u305d\u306e\u30ea\u30b9\u30af\u306f\u5e74\u9f62\u3068\u3068\u3082\u306b\u5897\u52a0\u3057\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u5730\u57df\u306b\u304a\u3051\u308b\u5fc3\u8840\u7ba1\u75be\u60a3\u306e\u8457\u3057\u3044\u8ca0\u62c5\u306f\u3001\u75c5\u72b6\u3092\u52b9\u679c\u7684\u306b\u7ba1\u7406\u3059\u308b\u305f\u3081\u306e\u8907\u5408\u6ce8\u5c04\u5264\u306e\u9700\u8981\u3092\u5897\u5927\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3067\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u5730\u57df\u5e02\u5834\u306e\u6210\u9577\u306f\u3001\u5e02\u5834\u53c2\u52a0\u8005\u306b\u3088\u308b\u6ce8\u5c04\u5264\u88fd\u9020\u80fd\u529b\u306e\u62e1\u5927\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\u306e\u5f37\u5316\u306b\u3088\u3063\u3066\u3082\u63a8\u9032\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e746\u6708\u306b\u306f\u3001Amneal Pharmaceuticals, Inc.\u304c2024\u5e74\u521d\u982d\u306b6\u3064\u306e\u65b0\u3057\u3044\u6ce8\u5c04\u5264\u88fd\u54c1\u3092\u767a\u58f2\u3057\u3001\u6ce8\u5c04\u5264\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u62e1\u5927\u3092\u7d99\u7d9a\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u62e1\u5927\u306b\u3088\u308a\u3001\u7c73\u56fd\u3067\u5229\u7528\u53ef\u80fd\u306a\u5546\u696d\u7528\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u7dcf\u6570\u304c\u5897\u52a0\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u5317\u7c73\u5e02\u5834\u306b\u304a\u3051\u308b\u8907\u5408\u6ce8\u5c04\u5264\u88fd\u54c1\u306e\u5c0e\u5165\u5897\u52a0\u3082\u3001\u5730\u57df\u6210\u9577\u3092\u3055\u3089\u306b\u4fc3\u9032\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e748\u6708\u306b\u306f\u3001Lupin Limited\u304c\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08U.S. FDA\uff09\u304cLupin\u306e\u63d0\u643a\u30d1\u30fc\u30c8\u30ca\u30fc\u3067\u3042\u308bForDoz Pharma Corporation\u306b\u7565\u5f0f\u65b0\u85ac\u627f\u8a8d\u7533\u8acb\uff08ANDA\uff09\u3092\u627f\u8a8d\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u30c9\u30ad\u30bd\u30eb\u30d3\u30b7\u30f3\u5869\u9178\u30ea\u30dd\u30bd\u30fc\u30e0\u6ce8\u5c04\u6db2\u306e2\u3064\u306e\u88fd\u5264\uff0850 mg\/25 mL\uff082 mg\/mL\uff09\u304a\u3088\u307320 mg\/10 mL\uff082 mg\/mL\uff09\u5358\u56de\u6295\u4e0e\u30d0\u30a4\u30a2\u30eb\uff09\u3092\u7c73\u56fd\u3067\u767a\u58f2\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<br \/>\n\u8907\u5408\u6ce8\u5c04\u5264\u5e02\u5834\u306f\u534a\u7d71\u5408\u578b\u3067\u3042\u308a\u3001\u3044\u304f\u3064\u304b\u306e\u91cd\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u304c\u5b58\u5728\u3057\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u3067\u4e8b\u696d\u3092\u5c55\u958b\u3059\u308b\u4e3b\u8981\u4f01\u696d\u306f\u3001\u53ce\u76ca\u30b7\u30a7\u30a2\u3092\u5f37\u5316\u3059\u308b\u305f\u3081\u306b\u69d8\u3005\u306a\u6709\u6a5f\u7684\u304a\u3088\u3073\u7121\u6a5f\u7684\u306a\u4e8b\u696d\u6226\u7565\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u308b\u4f01\u696d\u306b\u306f\u3001AbbVie Inc\u3001Accord BioPharma, Inc\u3001Bristol-Myers Squibb Company\u3001Ferring Pharmaceuticals\u3001Fresenius Kabi\u3001Indivior PLC\u3001Novartis AG\u3001Pfizer Inc\u3001Sun Pharmaceutical Industries Ltd\u3001Tolmar Pharmaceuticals, Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<br \/>\n\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411\u3068\u3057\u3066\u306f\u30012024\u5e744\u6708\u306bInnocan Pharma Corporation\u304c\u6162\u6027\u75bc\u75db\u6cbb\u7642\u7528\u306e\u30ea\u30dd\u30bd\u30fc\u30e0\u30fb\u30ab\u30f3\u30ca\u30d3\u30b8\u30aa\u30fc\u30eb\uff08LPT-CBD\uff09\u6ce8\u5c04\u5264\u306e\u6cbb\u9a13\u85ac\u7533\u8acb\u524d\uff08pre-IND\uff09\u4f1a\u8b70\u306e\u7533\u8acb\u66f8\u3092\u63d0\u51fa\u3057\u3001FDA\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u306e\u521d\u671f\u6bb5\u968e\u306b\u5165\u3063\u305f\u3053\u3068\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u307e\u305f\u30012023\u5e745\u6708\u306b\u306f\u3001American Regent, Inc.\u304c\u7279\u5b9a\u306e\u304c\u3093\u60a3\u8005\u3092\u6cbb\u7642\u3059\u308b\u305f\u3081\u306e\u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb\u30bf\u30f3\u30d1\u30af\u8cea\u7d50\u5408\u7c92\u5b50\u3092\u542b\u3080\u6ce8\u5c04\u7528\u61f8\u6fc1\u6db2\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u3068\u306f\u3001\u8907\u96d1\u306a\u6709\u52b9\u6210\u5206\u3001\u7279\u6b8a\u306a\u88fd\u5264\u3001\u7279\u5b9a\u306e\u6295\u4e0e\u7d4c\u8def\u3001\u307e\u305f\u306f\u85ac\u5264\u3068\u9001\u9054\u30c7\u30d0\u30a4\u30b9\u306e\u7d44\u307f\u5408\u308f\u305b\u3092\u7279\u5fb4\u3068\u3059\u308b\u6ce8\u5c04\u5264\u3092\u6307\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306f\u3001\u4e2d\u7a7a\u91dd\u3068\u6ce8\u5c04\u5668\u3092\u7528\u3044\u3066\u76ae\u819a\u3092\u8cab\u901a\u3057\u3001\u6cbb\u7642\u85ac\u3092\u4f53\u5185\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u305f\u3081\u306b\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u306f\u30012024\u5e74\u306b1,017.7\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u3066\u304a\u308a\u30012025\u5e74\u306b\u306f1,112.5\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u30012025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff098.52%\u3067\u529b\u5f37\u304f\u6210\u9577\u3057\u30012030\u5e74\u306b\u306f1,674.4\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u307e\u305a\u6162\u6027\u75be\u60a3\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5fc3\u8840\u7ba1\u75be\u60a3\u3001\u304c\u3093\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u6162\u6027\u75be\u60a3\u306e\u60a3\u8005\u6570\u304c\u5897\u52a0\u3059\u308b\u306b\u3064\u308c\u3066\u3001\u52b9\u679c\u7684\u3067\u6301\u7d9a\u7684\u306a\u85ac\u5264\u9001\u9054\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3068\u3057\u3066\u306e\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u306e\u9700\u8981\u304c\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002\u6b21\u306b\u3001\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u652f\u63f4\u3068\u627f\u8a8d\u304c\u5e02\u5834\u62e1\u5927\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002\u65b0\u85ac\u3084\u6539\u826f\u3055\u308c\u305f\u88fd\u5264\u306b\u5bfe\u3059\u308b\u8fc5\u901f\u306a\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u306f\u3001\u88fd\u54c1\u306e\u5e02\u5834\u6295\u5165\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u85ac\u5264\u9001\u9054\u6280\u8853\u306b\u304a\u3051\u308b\u9769\u65b0\u3001\u7279\u306b\u6a19\u7684\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u3084\u653e\u51fa\u5236\u5fa1\u6280\u8853\u306e\u9032\u6b69\u304c\u3001\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u3092\u5411\u4e0a\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u306e\u958b\u767a\u306b\u4f34\u3046\u9ad8\u3044\u7814\u7a76\u958b\u767a\u30b3\u30b9\u30c8\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u9ad8\u5ea6\u306a\u6280\u8853\u3068\u53b3\u683c\u306a\u81e8\u5e8a\u8a66\u9a13\u304c\u5fc5\u8981\u3068\u3055\u308c\u308b\u305f\u3081\u3001\u958b\u767a\u8cbb\u7528\u306f\u9ad8\u984d\u306b\u306a\u308a\u304c\u3061\u3067\u3059\u3002\u307e\u305f\u3001\u3053\u308c\u3089\u306e\u88fd\u5264\u306e\u88fd\u9020\u306b\u304a\u3051\u308b\u8907\u96d1\u6027\u3082\u8ab2\u984c\u3067\u3042\u308a\u3001\u7279\u6b8a\u306a\u8a2d\u5099\u3084\u5c02\u9580\u77e5\u8b58\u304c\u6c42\u3081\u3089\u308c\u308b\u305f\u3081\u3001\u751f\u7523\u30b3\u30b9\u30c8\u304c\u5897\u52a0\u3059\u308b\u50be\u5411\u306b\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01\u3001\u4ee3\u66ff\u88fd\u54c1\u306e\u8105\u5a01\u3001\u304a\u3088\u3073\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3046\u89b3\u70b9\u304b\u3089\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u3092\u901a\u3058\u3066\u5e02\u5834\u306e\u7af6\u4e89\u74b0\u5883\u3082\u8a55\u4fa1\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306f\u3001\u8907\u6570\u306e\u4e3b\u8981\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u308f\u305f\u3063\u3066\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6295\u4e0e\u7d4c\u8def\u5225\u3067\u306f\u3001\u7b4b\u8089\u5185\u6ce8\u5c04\uff08IM\uff09\u3001\u9759\u8108\u5185\u6ce8\u5c04\uff08IV\uff09\u3001\u76ae\u4e0b\u6ce8\u5c04\u306b\u5206\u985e\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u6295\u4e0e\u65b9\u6cd5\u304c\u7279\u5b9a\u306e\u6cbb\u7642\u30cb\u30fc\u30ba\u306b\u5bfe\u5fdc\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u88fd\u5264\u5225\u3067\u306f\u3001\u30ea\u30dd\u30bd\u30fc\u30e0\u3001\u30de\u30a4\u30af\u30ed\u30b9\u30d5\u30a3\u30a2\u3001\u304a\u3088\u3073\u305d\u306e\u4ed6\u306e\u9769\u65b0\u7684\u306a\u88fd\u5264\u304c\u542b\u307e\u308c\u3001\u3053\u308c\u3089\u306f\u85ac\u5264\u306e\u5b89\u5b9a\u6027\u3001\u6eb6\u89e3\u6027\u3001\u304a\u3088\u3073\u653e\u51fa\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u306b\u958b\u767a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u85ac\u5264\u5206\u5b50\u5225\u3067\u306f\u3001\u30ea\u30e5\u30fc\u30d7\u30ed\u30ea\u30c9\u3001\u30aa\u30af\u30c8\u30ec\u30aa\u30c1\u30c9\u3001\u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb\u3001\u30da\u30ac\u30b9\u30d1\u30eb\u30ac\u30fc\u30bc\u3001\u30ea\u30b9\u30da\u30ea\u30c9\u30f3\u306a\u3069\u3001\u69d8\u3005\u306a\u75be\u60a3\u9818\u57df\u3067\u4f7f\u7528\u3055\u308c\u308b\u4e3b\u8981\u306a\u85ac\u5264\u5206\u5b50\u304c\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u7528\u9014\u5225\u3067\u306f\u3001\u5fc3\u8840\u7ba1\u75be\u60a3\u3001\u304c\u3093\u3001\u4e2d\u67a2\u795e\u7d4c\u7cfb\u75be\u60a3\u3001\u7cd6\u5c3f\u75c5\u3001\u5185\u5206\u6ccc\u75be\u60a3\u3001\u305d\u306e\u4ed6\u306e\u75be\u60a3\u3068\u3044\u3063\u305f\u5e83\u7bc4\u306a\u6cbb\u7642\u9818\u57df\u304c\u5bfe\u8c61\u3068\u3055\u308c\u3066\u304a\u308a\u3001\u5404\u75be\u60a3\u306b\u5bfe\u3059\u308b\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u306e\u9069\u7528\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u306a\u3069\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u306a\u3069\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u306a\u3069\uff09\u306b\u7d30\u5206\u5316\u3055\u308c\u3001\u5404\u5730\u57df\u306e\u5e02\u5834\u898f\u6a21\u3068\u4e88\u6e2c\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u7406\u7684\u5206\u6790\u3067\u306f\u3001\u5317\u7c73\u304c2025\u5e74\u306b\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e00\u65b9\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3044\u3066\u6700\u3082\u9ad8\u3044\u5e74\u5e73\u5747\u6210\u9577\u7387\u3067\u6210\u9577\u3059\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u306e\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001AbbVie Inc.\u3001Accord BioPharma, Inc.\u3001Bristol-Myers Squibb Company\u3001Ferring Pharmaceuticals\u3001Fresenius Kabi\u3001Indivior PLC\u3001Novartis AG\u3001Pfizer Inc.\u3001Takeda Pharmaceutical Company Limited\u3001Tolmar Pharmaceuticals, Inc.\u306a\u3069\u306e\u4e3b\u8981\u306a\u5e02\u5834\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u3053\u308c\u3089\u306e\u8a73\u7d30\u306a\u5206\u6790\u3092\u901a\u3058\u3066\u3001\u8907\u96d1\u306a\u6ce8\u5c04\u5264\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u306e\u52d5\u5411\u3001\u5c06\u6765\u306e\u6a5f\u4f1a\u3001\u304a\u3088\u3073\u65b0\u305f\u306a\u30c8\u30ec\u30f3\u30c9\u3092\u5305\u62ec\u7684\u306b\u628a\u63e1\u3059\u308b\u305f\u3081\u306e\u8cb4\u91cd\u306a\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/75352"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=75352"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/75352\/revisions"}],"predecessor-version":[{"id":75355,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/75352\/revisions\/75355"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=75352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=75352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=75352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}